Jan 08, 2020
Immutep Expands Part C of TACTI-002 Due to Positive Data
Dec 18, 2019
INSIGHT-004 Clinical Trial Update
Nov 13, 2019
Immutep Announces European Patent Grant for LAG525 Antibody
Nov 07, 2019
Immutep Presents Positive Interim Data from Phase II TACTI-002 Trial at SITC
Oct 28, 2019
Operational Update
